Literature DB >> 22999493

Hypertrophic reprogramming of the left ventricle: translation to the ECG.

Joseph A Hill1.   

Abstract

Hypertrophic growth of the heart occurs in many clinical scenarios, and it confers substantially increased risk of untoward sequelae. Among them, transition to ventricular dilation, wall thinning, contractile dysfunction, and a clinical syndrome of heart failure are paramount. Left ventricular hypertrophy (LVH) is typically diagnosed by either electrocardiography or echocardiography. However, these two means of assessing hypertrophic transformation of the left ventricle can sometimes disagree. At one level, this may not be surprising as the two methodologies are based on entirely divergent signals: electrical potential between two places on the surface of the skin and ultrasound energy reflected from the ventricle itself. Echocardiography is an effective means of assessing ventricular mass, which is a cardinal feature of LVH. Importantly, however, LVH is characterized by a wide range of remodeling events beyond simple increases in muscle mass. Electrocardiographic changes in LVH are reflective of the electrophysiological aspects of hypertrophic transformation. Here, I present an overview of the complex biology of left ventricular hypertrophy with an eye toward enhancing our understanding of its ECG manifestations. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22999493      PMCID: PMC3483360          DOI: 10.1016/j.jelectrocard.2012.08.003

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  56 in total

1.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

Authors:  Ravi G Assomull; Sanjay K Prasad; Jonathan Lyne; Gillian Smith; Elizabeth D Burman; Mohammed Khan; Mary N Sheppard; Philip A Poole-Wilson; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

2.  Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice.

Authors:  Sandra B Haudek; Ying Xia; Peter Huebener; John M Lee; Signe Carlson; Jeff R Crawford; Darrell Pilling; Richard H Gomer; JoAnn Trial; Nikolaos G Frangogiannis; Mark L Entman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

Review 3.  The role of autophagy in the heart.

Authors:  K Nishida; S Kyoi; O Yamaguchi; J Sadoshima; K Otsu
Journal:  Cell Death Differ       Date:  2008-11-14       Impact factor: 15.828

Review 4.  Cardiac plasticity.

Authors:  Joseph A Hill; Eric N Olson
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

5.  Myofibroblasts induce ectopic activity in cardiac tissue.

Authors:  Michele Miragoli; Nicolò Salvarani; Stephan Rohr
Journal:  Circ Res       Date:  2007-09-13       Impact factor: 17.367

6.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Authors:  Katherine C Wu; Robert G Weiss; David R Thiemann; Kakuya Kitagawa; André Schmidt; Darshan Dalal; Shenghan Lai; David A Bluemke; Gary Gerstenblith; Eduardo Marbán; Gordon F Tomaselli; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-06-24       Impact factor: 24.094

7.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

Review 8.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

9.  Osteopontin expression of circulating T cells and plasma osteopontin levels are increased in relation to severity of heart failure.

Authors:  Hirofumi Soejima; Atsushi Irie; Takashi Fukunaga; Yoko Oe; Sunao Kojima; Koichi Kaikita; Hiroaki Kawano; Seigo Sugiyama; Michihiro Yoshimura; Hideki Kishikawa; Yasuharu Nishimura; Hisao Ogawa
Journal:  Circ J       Date:  2007-12       Impact factor: 2.993

10.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

View more
  6 in total

Review 1.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

2.  Reverse electrical remodeling following pressure unloading in a rat model of hypertension-induced left ventricular myocardial hypertrophy.

Authors:  Mihály Ruppert; Sevil Korkmaz-Icöz; Shiliang Li; Béla Merkely; Matthias Karck; Tamás Radovits; Gábor Szabó
Journal:  Hypertens Res       Date:  2017-01-26       Impact factor: 3.872

3.  Seamens' Sign: a novel electrocardiogram prediction tool for left ventricular hypertrophy.

Authors:  Philip Walker; Cathy A Jenkins; Jeremy Hatcher; Clifford Freeman; Nickolas Srica; Bryant Rosell; Eriny Hanna; Cooper March; Charles Seamens; Alan Storrow; Nicole McCoin
Journal:  PeerJ       Date:  2022-05-31       Impact factor: 3.061

4.  Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.

Authors:  Yvonne Lee Yin Leng; Yuling Zhou; Honghong Ke; Herbert Jelinek; Joel McCabe; Hassan Assareh; Craig S McLachlan
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Electrocardiogram derived QRS duration associations with elevated central aortic systolic pressure (CASP) in a rural Australian population.

Authors:  Yvonne Yin Leng Lee; Paul Reidler; Herbert Jelinek; Yung Seng Lee; Yuling Zhou; Brett D Hambly; Joel McCabe; Slade Matthews; Honghong Ke; Hassan Assareh; Craig S McLachlan
Journal:  Clin Hypertens       Date:  2016-02-16

6.  Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their Receptors.

Authors:  Simona Nemska; Laurent Monassier; Max Gassmann; Nelly Frossard; Reza Tavakoli
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.